Liposome Mediated Transfer of Marker and Cytokine Genes Into Rat and Human Glioblastoma Cells in Vitro and in Vivo

References

• Walker M. D., Green S. B., Byar D. P., et al. Randomised comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Eng. J. Med. 1980; 303: 1323
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Mule J. J. Experimental and clinical studies of cytokine gene-modified cells. Human Gene Therapy 1994; 5: 153
   PubMed Web of Science ®Google Scholar
• Tracey K. J., Cerami A. Pleiotropic Effects of TNF in Infection and Neoplasia: Beneficial, Inflammatory, Catabolic, or Injurious. Tumor Necrosis Factors, B. B. Aggarwal, J. Vilcek. Marcel Dekker, Inc., New York 1992; 431
   Google Scholar
• Tracey K. J., Morgello S., Koplin B., et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. J. Clin. Invest 1990; 86: 2014
   PubMed Web of Science ®Google Scholar
• Malik S. T.A., Balkwill F. R. Antiproliferative and antitumor activity of TNF in vitro and in vivo. Tumor Necrosis Factors, B. B. Aggarwal, J. Vilcek. Marcel Dekker, Inc., New York 1992; 239
   Google Scholar
• Blankenstein T., Qin Z., Überla K., et al. Tumor suppression after tumor cell-targeted tumor necrosis gene transfer. J. Exp. Med. 1991; 173: 1047
   PubMed Web of Science ®Google Scholar
• Qin Z., Krüger-Krasagakes S., Kunzendorf U., et al. Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented Metastasis. J. Exp. Med. 1993; 178: 355
   Google Scholar
• Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50: 555
   PubMed Web of Science ®Google Scholar
• Teng M. N., Park B. H., Koeppen H. K., Tracey K. J., Fendly B. M., Schreiber H. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. USA 1991; 88: 3535
   PubMed Web of Science ®Google Scholar
• Asher A. L., Mule J. J., Kasid A., Restifo N. P., Salo J. C., Reichert C. M., Jaffe G., Fendly B., Kriegler M., Rosenberg S. A. Murine tumor cells transduced with the gene for tumor necrosis factor-α. J. Immunol. 1991; 146: 3227
   PubMed Web of Science ®Google Scholar
• Balkwill F. R. Cytokines in Cancer Therapy. Oxford University Press. 1989
   Google Scholar
• Munoz F. M.A., Armas P. R., et al. Differential effects of tumor necrosis factor on the growth and differentiation of neuroblastoma and glioma cells. Exp. Cell Res. 1991; 194: 161
   Google Scholar
• Tartaglia L. A., Rothe M., Hu Y. F., et al. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993; 73: 213
   PubMed Web of Science ®Google Scholar
• Sakuma S., Sawamura Y., Tada M., et al. Responses of human glioblastoma cells to human natural tumor necrosis factor-alpha: susceptibility, mechanism of resistance and cytokine production studies. J. Neurooncol. 1993; 15: 197
   PubMed Web of Science ®Google Scholar
• Barna B. P., Barnett G. H., Jacobs B. S., et al. Divergent responses of human astrocytoma and non-neoplastic astrocyres to tumor necrosis factor alpha involve the 5 kD tumor necrosis factor receptor. J. Neuroimmunol. 1993; 43: 185
   Google Scholar
• Sidhu R. S., Bollon A. P. Tumor necrosis factor activities and cancer therapy -a perspective. Pharmacol. Therapy 1993; 57: 79
   PubMed Web of Science ®Google Scholar
• Beyaert R, Fier W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS-Lett 1994; 340(1–2)9
   Google Scholar
• Heller R. A., Krönke M. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biology 1994; 126: 5
   PubMed Web of Science ®Google Scholar
• Lynn W. S., Mathews D., Cloyd M., et al. Intracellular Ca2+ and cytotoxicity. Arch. Environ Health 1989; 44: 323
   PubMed Web of Science ®Google Scholar
• Beutler B., Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocrinol. Rev. 1988; 9: 57
   PubMed Web of Science ®Google Scholar
• Wong G. H.W., Elwell J. H., Oberley L. W., et al. Manganese superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989; 58: 923
   PubMed Web of Science ®Google Scholar
• Wong G. H.W., Goeddel D. V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 1988; 242: 941
   PubMed Web of Science ®Google Scholar
• Dayer J. M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 1985; 162: 2163
   PubMed Web of Science ®Google Scholar
• Larrick J. W., Wright S. C. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 1990; 4: 3215
   PubMed Web of Science ®Google Scholar
• Del Maestro R. F. An approach to free radicals in medicine and biology. Acta Physiol. Scand. Suppl. 1980; 492: 153
   PubMedGoogle Scholar
• Fridovich I. The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity; superoxide dismutases provide an important defense. Science 1978; 201: 875
   PubMed Web of Science ®Google Scholar
• Walsh C., Cepko C. L. Clonally related cortical cells show several migration patterns. Science (Washington DC) 1988; 241: 1342
   PubMedGoogle Scholar
• Salmons B., Günzburg W. H. Targeting of retroviral vectors for gene therapy. Human Gene Therapy 1993; 4: 129
   PubMed Web of Science ®Google Scholar
• Sparmann G., Walther W., Salmons B., et al. Conditional expression of TNF: a system for inducible cytotoxicity. Int. J. Cancer., In press
   Google Scholar
• Weis J., Fine S. M., Sanes J. R. Integration site-dependent transgene expression used to mark subpopulations of cells in vivo: a example from the neuromuscular junction. Brain-Pathol. 1992; 2(1)31
   Google Scholar
• Gao X., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Comm. 1991; 179: 280
   PubMed Web of Science ®Google Scholar
• Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor / tumor necrosis factor from human monocytes. J. Immunol. Meth. 1986; 95: 99
   PubMed Web of Science ®Google Scholar
• Brockhaus M., Schoenfeld H. J., Schlaeger E. J., et al. Identification of two types of TNF receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 3127
   PubMed Web of Science ®Google Scholar
• Tartaglia L A, Rothe M, Hu Y F, Goeddel D V. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell., 23 1993; 73(2)213–6
   PubMed Web of Science ®Google Scholar
• Tada M., Diserens A.-C., Desbaillets I., De Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J. Neurosurg. 1994; 80: 1063
   PubMed Web of Science ®Google Scholar
• Kagan I B., Baldwin R L., Munoz D, Wisnieski B J. Formation of ion-permeable channals by tumor necrosis factor-α. Science 1992; 255: 1427–1430
   PubMed Web of Science ®Google Scholar
• San H., Yang Z.-Y., Pompili V. J., Jaffe M. L., Plautz G. E., Xu L., Felgner J. H., Wheeler C. J., Felgner P. L., Gao X., Huang L., Gordon D., Nabel G. J., Nabel E. G. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Human Gene Therapy 1993; 4: 781
   PubMed Web of Science ®Google Scholar
• Mizuno M., Yoshida J., Oyama H., Sugita K. Growth inhibition of glioma cells by liposome-mediated cell transfection with tumor necrosis factor-α gene – Ist enhancement by prior γ-interferon treatment. Neurologia medico-chirurgica 1992; 32(12)873
   PubMedGoogle Scholar
• Tashiro T., Yoshida J., Mizuno M., Sugita K. Reinforced cytotoxicity of lymphokine-activated killer cells towards glioma cells by transfection with the tumor necrosis factor-α gene. J. Neurosurg. 1993; 78: 252
   Google Scholar
• Schiller J. H., Storer B. E., Witt P. L., Alberti D., Tombes M. B., Arzomanian R., Proctor R. A., McCarthy D., Brown R. R., Voss S. D., et al. Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res 1991; 51(6)1651
   Google Scholar